Evidence
Stanford-rooted research, recognized by the field.
Two Stanford worldwide-exclusive patents. Peer-reviewed publications in Surgical Innovation. HLTH 2023 Best in Class. MedTech Innovator 2026. The credibility layer beneath the platform.
Publications
2
Peer-reviewed research in Surgical Innovation, with Stanford Biodesign-affiliated authors.
See all →
Patents
6
Two Stanford worldwide-exclusive patents plus four non-provisional / provisional applications covering the CV pipeline.
See all →
Awards & Recognition
6
HLTH 2023 Best in Class, MedTech Innovator 2026, SXSW Pitch Finalist, Stanford Biodesign, UCSF, and more.
See all →
Want the deep cuts?
Investor diligence access unlocks the complete research archive, technical deep-dives, and the detailed pilot data.